Physician profile
Alyssa Bower
NPI 1770345456
$2,917.25
in general payments reported to CMS, 2019-2025
17 companies · $1,516 in 2025
The $1,516 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,402 · 2025: $1,516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,619 · Education: $298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,619.00 |
| Education | $298.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $444.09 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $390.36 | 2024-2025 | Dupixent, Libtayo |
| Janssen Biotech, INC. | $343.36 | 2024-2025 | Tremfya |
| Incyte Corporation | $282.30 | 2024-2025 | Opzelura, Opzelura |
| Pfizer INC. | $255.33 | 2024-2025 | |
| Arcutis Biotherapeutics, INC. | $248.99 | 2024-2025 | Zoryve |
| Genzyme Corporation | $238.78 | 2024-2025 | |
| Galderma Laboratories, L.P. | $170.02 | 2024-2025 | Nemluvio, Aklief |
| Amgen INC. | $141.25 | 2024-2025 | Otezla, Otezla |
| Novartis Pharmaceuticals Corporation | $136.13 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $85.47 | 2024 | |
| Ucb, INC. | $61.70 | 2025 | Bimzelx |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $35.47 | 2024-2025 | Cabtreo, Jublia, Siliq |
| Dermavant Sciences, INC. | $24.57 | 2024 | Vtama |
| Lilly USA, LLC | $21.00 | 2024 | Olumiant |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solta Medical, A Division of Bausch Health US, LLC | $19.51 | 2025 | Fraxel |
| Almirall LLC | $18.92 | 2024 | Klisyri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyssa Bower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.